Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Pohanka

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Current Opinion in Urology|February 27, 2001
New immunosuppressive drugs: an updateE Pohanka
Prostaglandins, Leukotrienes, and Medicine|May 1, 1986
Effect of a single pentoxifylline administration on platelet sensitivity, plasma factor activity, plasma-6-oxo-PGF1 alpha and thromboxane B2 in healthy volunteersE Pohanka, H Sinzinger
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 1996
Is treatment with interferon-alpha in renal transplant recipients still justified?E Pohanka, J Kovarik
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|September 14, 2012
Dialysis in diabetic patients: hemodialysis and peritoneal dialysis. Pros and consG Biesenbach, E Pohanka
Lancet (London, England)|October 22, 1988
Progression of chronic renal failureO Traindl, E Pohanka, J Kovarik
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Radiolabelled platelets and prostacyclin in diagnosis and treatment of transplant rejectionC Leithner, H Sinzinger, M Schwarz, et al.
Acta Medica Austriaca|January 1, 1982
[Acute inhibition of angiotensin-converting enzyme by captopril. Hemodynamic and biochemical aspects in normotension and essential hypertension]B Stanek, H Templ, E Pohanka, et al.
Transplantation Proceedings|May 28, 2005
Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipientsE Pohanka, R Margreiter, V Sparacino, et al.
Wiener Klinische Wochenschrift|March 2, 1990
[OKT 3 treatment of kidney transplant recipients]G J Zlabinger, W Ulrich, E Pohanka, et al.
Clinical Nephrology|December 1, 1982
Increased deposition of 111Indium labelled platelets in chronically rejected kidney transplantsC Leithner, H Sinzinger, M Schwarz, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Current Opinion in Urology|February 27, 2001
New immunosuppressive drugs: an updateE Pohanka
Prostaglandins, Leukotrienes, and Medicine|May 1, 1986
Effect of a single pentoxifylline administration on platelet sensitivity, plasma factor activity, plasma-6-oxo-PGF1 alpha and thromboxane B2 in healthy volunteersE Pohanka, H Sinzinger
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 1996
Is treatment with interferon-alpha in renal transplant recipients still justified?E Pohanka, J Kovarik
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|September 14, 2012
Dialysis in diabetic patients: hemodialysis and peritoneal dialysis. Pros and consG Biesenbach, E Pohanka
Lancet (London, England)|October 22, 1988
Progression of chronic renal failureO Traindl, E Pohanka, J Kovarik
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Radiolabelled platelets and prostacyclin in diagnosis and treatment of transplant rejectionC Leithner, H Sinzinger, M Schwarz, et al.
Acta Medica Austriaca|January 1, 1982
[Acute inhibition of angiotensin-converting enzyme by captopril. Hemodynamic and biochemical aspects in normotension and essential hypertension]B Stanek, H Templ, E Pohanka, et al.
Transplantation Proceedings|May 28, 2005
Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipientsE Pohanka, R Margreiter, V Sparacino, et al.
Wiener Klinische Wochenschrift|March 2, 1990
[OKT 3 treatment of kidney transplant recipients]G J Zlabinger, W Ulrich, E Pohanka, et al.
Clinical Nephrology|December 1, 1982
Increased deposition of 111Indium labelled platelets in chronically rejected kidney transplantsC Leithner, H Sinzinger, M Schwarz, et al.
Pageof 8